One of the fundamental questions concerning expression and function of dimeric enzymes involves the impact of naturally occurring mutations on subunit assembly and heterodimer activity. This question is of particular interest for the human enzyme galactose-1-phosphate uridylyltransferase (GALT), impairment of which results in the inherited metabolic disorder galactosemia, because many if not most patients studied to date are compound heterozygotes rather than true molecular homozygotes. Furthermore, the broad range of phenotypic severity observed in these patients raises the possibility that allelic combination, not just allelic constitution, may play some role in determining outcome. In the work described herein, we have selected two distinct naturally occurring null mutations of GALT, Q188R and R333W, and asked the questions (i) what are the impacts of these mutations on subunit assembly, and (ii) if heterodimers do form, are they active? To answer these questions, we have established a yeast system for the coexpression of epitopetagged alleles of human GALT and investigated both the extent of specific GALT subunit interactions and the activity of defined heterodimer pools. We have found that both homodimers and heterodimers do form involving each of the mutant subunits tested and that both heterodimer pools retain substantial enzymatic activity. These results are significant not only in terms of their implications for furthering our understanding of galactosemia and GALT holoenzyme structure-function relationships but also because the system described may serve as a model for similar studies of other complexes composed of multiple subunits.
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One of the fundamental questions raised by studies of the human enzyme galactose-1-phosphate uridylyltransferase (EC 2.7.7.12; GALT) concerns the role of subunit interaction on holoenzyme function and the impact of naturally occurring mutations on those interactions. Human GALT, impairment of which results in the potentially lethal disorder galactosemia, has been demonstrated to function as a dimer (1-7), ostensibly composed of identical subunits. However, the marked heterogeneity of naturally occurring point mutations identified in the GALT loci of galactosemia patients (e.g., ref. 8) indicates that many, if not most, of these patients are compound heterozygotes rather than true molecular homozygotes. The GALT enzymes expressed in these individuals, therefore, would be expected to consist of mixtures of homodimers and compound heterodimers, present in proportions reflective of the relative abundance, stability, and affinities of the individual subunits involved. This added level of heterogeneity may contribute to the broad range of phenotypic severity (for review, see ref. 9 ) observed for patients with galactosemia.
That normal human GALT functions as a dimer has been determined by gel filtration column chromatography, SDS/ PAGE after chemical cross-linking, and sucrose density gradient ultracentrifugation of purified or enriched preparations derived from a variety of tissues (1-7). Holoenzyme molecular weight estimates from these studies have ranged from 67,000 to 88,000, with respective monomer sizes, as determined by SDS/PAGE, at between 31,000 and 46,000. The unmodified 379-amino acid polypeptide predicted from the sequence of the cloned human GALT cDNA (10, 11) has a predicted molecular weight of 43,179. GALT enzymes from Escherichia coli and Saccharomyces cerevisiae also have been studied, with the conclusion that both function as dimers with holoenzyme and subunit molecular weights of 80,200 and 41,000 (12) and of 86,100 and 38,000 (13), respectively. Indeed, Wedekind et al. (14) recently crystallized the E. coli enzyme and determined its structure at 1.8-A resolution as that of a dimer composed of identical subunits.
To determine whether each GALT subunit contains its own active site or whether the two subunits work in concert to create a single active site, Frey et al. (15) performed measurements of the first half-reaction for the purified E. coli enzyme. Their results, that 2 mol of glucose 1-phosphate were released per mol of holoenzyme, strongly suggested that each subunit contains its own active site. These data did not, however, address the question of possible synergistic or regulatory interactions between subunits and their respective active sites.
Nadler et al. (1) addressed the issue of functional interaction of subunits when they demonstrated interallelic complementation of naturally occurring mutant GALT enzymes in hybrid cells derived by pairwise fusion of skin fibroblasts from seven galactosemic patients. Of 28 hybrids, 3 exhibited detectable GALT activity, ostensibly reflecting the presence of active compound heterodimers composed of subunits derived from each of the two fused lines. The GALT activity produced by these hybrid cells was similar to that of the normal enzyme in terms of Km values, pH optimum, and electrophoretic mobility on starch gels but differed in values for specific activity and Vmax, as well as properties of thermal stability (1) . While these data are compelling, they are nonetheless extremely complex to interpret due to the lack of molecular characterization of the patients involved and the lack of information regarding extent of subunit interaction in the hybrids. Furthermore, unless all of the patients were true molecular homozygotes, which seems unlikely, each pairwise fusion could have involved GALT subunits derived from as many as four different alleles.
In an effort to test more directly both the extent of physical association of subunits encoded by known alleles of GALT and the impact of those interactions on enzymatic activity, we have modified our previously reported yeast expression system for human GALT (16, 17) to enable the coexpression of epitopetagged alleles within single cells. Here we report the results of a series of experiments designed to investigate subunit interAbbreviation: GALT, galactose-1-phosphate uridylyltransferase.
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action with proteins derived from wild-type human GALT sequences as well as GALT sequences carrying each of two previously identified naturally occurring null mutations, Q188R and R333W. These data were obtained from experiments involving coprecipitation of epitope-tagged subunits coupled with activity assays and Western blot analyses, gel filtration column chromatography, and a modified form of the yeast two-hybrid system. Our results demonstrate not only that both homodimers and heterodimers do form involving each of these two mutants subunits but also that both heterodimer pools retain substantial enzymatic activity.
MATERIALS AND METHODS Yeast Strains, Plasmids, and Expression Studies. All yeast strains (yJFK1 and yJFK18) and yeast expression plasmids (pPEyl, pLMy2, pLMy5, and pPEy3) employed in this study have been described (16) (17) (18) . All procedures including yeast transformations, culture manipulations, extract preparations, and GALT enzymatic assays were performed as described (16) (17) (18) . The Q188R mutation was introduced into the human GALT cDNA as described (16) . The R333W mutation was introduced into the human GALT cDNA by site-directed mutagenesis as described elsewhere (19) . Sequence encoding the 12CA5 epitope tag after a start codon (MYPYDVPDYA) was introduced in-frame onto the 5' end of the human GALT coding sequence by site-directed mutagenesis (19) . The sequence encoding the HIS6 epitope tag after a start codon (MHHHHHH) was introduced onto the 5' end of the human GALT coding sequence by PCR. All plasmid manipulations were performed using standard techniques (20) .
Yeast Two-Hybrid System Studies. A modified form of the yeast two-hybrid system/interaction trap (21, 22) was used to probe human GALT subunit interaction, as described (18) .
18-Galactosidase Activity Assays. All 13-galactosidase assays were performed in quadruplicate, representing extracts prepared from two separate colonies, each assayed at two different concentrations within the linear range of the assay defined for that sample, as described (18) . Activity values were derived by comparing raw data from each spectrophotometric assay with a standard curve generated using purified enzyme. Finally, all data were normalized according to the average activity detected in extracts representing wild-type human GALT homodimeric interactions. Western Blot Analysis. Western blot analysis was performed essentially as described (18) (Fig. 1) . Expression levels of identical GALT sequences encoded by each of the two Genetics: Elsevier et al. Gel filtration column chromatography of whole cell lysate prepared from yeast expressing 12CA5-tagged human GALT. Elution profiles are presented for both GALT activity and immunoreactive signals. All fractions tested were normalized to the peak value for that assay. The predicted elution positions for GALT monomer and dimer are indicated. subunits, wild type or mutant, were affinity-precipitated using a nickel resin, and the resultant pellets were probed for presence of the 12CA5-tagged subunit by Western blot analysis with an anti-12CA5 monoclonal antibody (Fig. 3) .
As illustrated in Fig. 4A , strong signals were detected in lanes representing wild-type GALT homodimers (lane 5), wildtype/Q188R-GALT heterodimers (lane 6), Q188R-GALT homodimers (lane 7), wild-type GALT/R333W-GALT heterodimers (lane 8), and R333W-GALT homodimers (lane 9), indicating interallelic subunit interaction. As a control for specificity of the nickel-HIS6 interaction, extracts containing 12CA5-GALT, but no HIS6-GALT, also were analyzed, revealing no detectable signal (lane 3). Similarly, as a control for potentially spurious interaction of preformed GALT dimers during the affinity-precipitation procedure, separate extracts containing 12CA5-tagged GALT and HIS6-tagged GALT were mixed just prior to start of the precipitation procedure. Again, no 12CA5 signal was detected (lane 4). To confirm the presence of 12CA5-tagged GALT in each of these control lysates, both also were subjected to Western blot analysis with an anti-12CA5 antibody prior to affinity precipitation (lanes 1 and 2 of 12CA5-tagged GALT, is noticeably more intense than is that in lane 2, representing one 12CA5-tagged copy of GALT. Finally, as a control for efficiency of the nickel affinity precipitations, parallel samples representing all lanes also were subjected to Western blot analysis with an anti-GALT polyclonal antiserum that detects both 12CA5-and HIS6-tagged forms of the protein. As expected, strong signals were detected in all lanes except lane 3 (Fig. 4A) .
As a final control to rule out nonspecific protein-protein interactions with HIS6-tagged GALT, an affinity precipitation experiment was performed using a metabolically radiolabeled yeast lysate containing HIS6-GALT. As illustrated (Fig. 4B) , although the crude lysate contained innumerable bands, the affinity-purified sample demonstrated only a single band migrating to the correct position on the gel for HIS6-GALT.
Modified Yeast Two-Hybrid Experiments. As an independent test of subunit interaction in human GALT, we have applied a modified form of the yeast two-hybrid system, as described (18, 21, 22) . In brief, cells were cotransformed with two plasmids, each of which encoded a defined subunit of human GALT fused in-frame with one-half of a transcriptional activator-either the DNA binding domain of bacterial LexA or the acidic activating domain of yeast GAL4. In each cotransformed cell, if the two encoded subunits of GALT interact, their fusion partners should be brought into close approximation and a functional transcription factor reconstituted capable of activating expression of a ,3-galactosidase reporter gene. If the two GALT subunits do not interact, the two halves of the transcription factor should remain independent and the reporter gene should remain silent. As illustrated in Fig. 5 , extracts representing all of the appropriate controls were negative, and extracts representing interactions corresponding to wild-type GALT homodimer, wild-type GALT/ Q188R-GALT heterodimer, Q188R-GALT homodimer, wildtype GALT/R333W-GALT heterodimer, and R333W-GALT homodimer were positive, again demonstrating interaction between all of the subunits tested.
Activity of Defined GALT Homodimer and Heterodimer Pools. We next tested each defined homodimer and heterodimer pool for GALT activity (Fig. 6) . Nickel-affinity precipitations were performed in triplicate on extracts prepared from yeast coexpressing the indicated HIS6-tagged mutant alleles of GALT with 12CA5-tagged alleles of either wild-type GALT or mutant GALT. From each set, one pellet was subjected to Western blot analysis with the anti-12CA5 antibody, one pellet was subjected to Western blot analysis with the anti-GALT polyclonal antiserum, and one pellet was analyzed for the presence of GALT activity. As a reference point against which to measure the mutant homodimer and heterodimer activities, extracts expressing both HIS6-tagged and 12CA5-tagged forms of wild-type GALT also were investigated. Finally, all activity assays were repeated three times for quantitative analysis.
Pellets derived from each nickel-affinity precipitation procedure, termed "heterodimer pellets," would be expected to include a mixture of two forms of GALT: (i) HIS6-tagged GALT homodimers and (ii) HIS6-tagged GALT/12CA5-tagged GALT heterodimers. As demonstrated in Fig. 4 , no 12CA5-tagged GALT homodimers should be present due to the specificity of the nickel affinity precipitation. Furthermore, no 12CA5-tagged GALT homodimers should have been able to reform from subunits dissociated from heterodimers during the course of the 30-min activity assay, as demonstrated by incubating "heterodimer pellets" in reaction buffer at the appropriate temperature for 40 min, centrifuging the sample to separate any dissociated 12CA5-tagged subunits from the bound HIS6-tagged subunits, and then analyzing both fractions by Western blot with the anti-12CA5 antibody. No diminution of signal was observed in pellets analyzed after the 40-min incubation, and no 12CA5 signal was detected in lanes representing supernatants (data not shown). Finally, because ,ug (anti-GALT panel) of crude extract prepared from yeast coexpressing the indicated alleles of human GALT were subjected to GALT activity assay as well as Western blot analyses using each of the antibodies indicated. For each extract, the HIS6-tagged allele is indicated above the line; the 12CA5-tagged allele is indicated below the line. All GALT activity values were normalized according to the wild-type control.
homodimers of both Q188R-and R333W-GALT are catalytically inactive (Figs. 1 and 6 ), any activity detected in each pellet must reflect activity of the corresponding heterodimer pool.
As illustrated in Fig. 6 , strong signals were detected in all lanes with both antibodies, indicating that all precipitations worked well. Furthermore, wild-type GALT homodimer exhibited substantial activity, both Q188R and R333W mutant GALT homodimers exhibited no detectable activity, and both heterodimer pellets exhibited between 20 and 30% of the activity seen with wild-type homodimers.
DISCUSSION
The experiments presented herein explore the impact of two naturally occurring mutations, Q188R and R333W, on human GALT dimer formation and activity. The Q188R mutation was selected for study because it accounts for 60-70% of the classic galactosemia alleles identified in Caucasian patients studied to date (26, 27) . Furthermore, it impacts a position only two codons from the presumed active site of the enzyme. The R333W mutation was selected for study because, in contrast to Q188R, it impacts sequence distal to the active site of the enzyme, both in linear terms and as predicted by homology to the bacterial enzyme structure (14) .
Two fundamental questions were asked, (i) what are the impacts of these two mutations on subunit assembly and (ii) if heterodimers do form, are they active? To address these questions, we have established and applied a yeast model system for the coexpression and analysis of defined epitopetagged alleles of human GALT. Our results demonstrate that both mutant forms of GALT remain competent to form homodimers and heterodimers with the wild-type subunit, and that both mutant/wild-type heterodimers retain substantial enzymatic activity despite the fact that each includes one subunit that, at least in homodimeric form, is completely catalytically inactive.
Both of the epitope tags used in this study, HIS6 and 12CA5, were introduced onto the amino terminus of the human GALT sequence, a region that is highly divergent through evolution (10, 11, 28) . As illustrated in Fig. 1 , neither tag appears to have exerted any significant effect on specific activity of the GALT protein.
The recently reported crystal structure of bacterial GALT (14) indicates that the amino termini of both subunits Proc. Natl. Acad. Sci. USA 93 (1996) reside on the surface of the holoenzyme, perhaps explaining the human enzyme's tolerance to modification reported herein. As reported, both the Q188R (16, 17) and R333W (29) mutations are associated with complete loss of enzymatic activity in the homodimeric state. The significance of the slight diminution of protein abundance observed herein for both untagged mutant proteins remains unclear.
While GALT preparations from a number of different sources have been analyzed with respect to size (1-7, 12, 13), these analyses have followed activity of the enzyme rather than simple presence of the protein, leaving open the possibility that monomeric (or multimeric) pools of GALT exist but are inactive. The gel filtration column chromatography results reported herein (Fig. 2) demonstrate that tagged human GALT produced within the context of the yeast expression system migrates as a dimer. These data are consistent with those reported for native human GALT (2-4), suggesting that neither expression within the yeast system nor presence of the epitope tags perturbs the subunit association properties of the human enzyme. The data presented herein also are significant because no pools other than dimer were detected, despite the fact that we followed the migration of both GALT protein and GALT activity through the column. Clearly, since no monomer or higher-order pools of GALT were detected, the question remains open as to whether or not such species would be active.
We have presented herein two sets of experiments that demonstrate interaction of both wild-type and mutant subunits of human GALT. While the coprecipitation experiments have demonstrated direct physical interaction of subunits, the modified yeast two-hybrid system experiments have corroborated these results. Indeed, the indirect nature of the two-hybrid system renders it a qualitative rather than a quantitative assay, so that the small differences observed between samples representing different GALT alleles (Fig. 5 ) may or may not reflect true differences in the affinities of the subunits involved.
The data presented herein demonstrating activity of heterodimers (Fig. 6 ) yielded results quantitatively similar, although not identical, to those that would have been expected under idealized circumstances: with all subunit assortments random, the probability of affinity precipitation for any dimer independent ofwhether it includes one HIS6-tagged subunit or two and all heterodimers 50% as active as wild-type homodimers. In this idealized circumstance, one would have predicted the heterodimer pellets analyzed herein, composed of 2/3 heterodimers and 1/3 HIS6-tagged mutant homodimers, to exhibit 33% as much GALT activity as the positive control.
Finally, the observation that both of the naturally occurring mutant subunits studied remained competent to interact with wild-type GALT is significant because it furthers the possibility that allelic combination and not just allelic constitution may play some role in defining holoenzyme function, and thereby patient outcome. Of course, in attempting to extend from the results reported herein to the human system, it is important to recognize that the possibility remains that other factors or conditions present in human cells, and absent in yeast, or visa versa, may impact GALT expression and/or function in galactosemic patients or carriers. The results reported herein were derived using a yeast model system to overexpress a human protein and, therefore, must alw,tys be interpreted with caution. Nonetheless, in addition /to the results reported herein, the system described herBh lends itself, via sequential affinity precipitation, to isAation of defined heterodimer or compound heterodimer poob, thereby facilitating a more detailed study of these hybrid enzymnes and their biochemical properties. I
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